Sandbox chemo1: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) m (→GnRH agonists) |
No edit summary |
||
| Line 105: | Line 105: | ||
====== Adrenocortical suppressants ====== | ====== Adrenocortical suppressants ====== | ||
* [[Mitotane|Mitotane (Lysodren)]] | * [[Mitotane|Mitotane (Lysodren)]] | ||
---- | ---- | ||
===== Antiandrogens ===== | ===== Antiandrogens ===== | ||
| Line 244: | Line 206: | ||
===== Megakaryocyte growth factors ===== | ===== Megakaryocyte growth factors ===== | ||
* [[Eltrombopag|Eltrombopag (Promacta)]] | * [[Eltrombopag|Eltrombopag (Promacta)]] | ||
---- | ---- | ||
| Line 270: | Line 229: | ||
{{Button|Miscellaneous}} | {{Button|Miscellaneous}} | ||
===== Bisphosphonate ===== | ===== Bisphosphonate ===== | ||
* [[Zoledronic Acid|Zoledronic Acid (Zometa)]] | * [[Zoledronic Acid|Zoledronic Acid (Zometa)]] | ||
===== HDAC inhibitors ===== | ===== HDAC inhibitors ===== | ||
| Line 289: | Line 240: | ||
===== Hedgehog pathway inhibitors ===== | ===== Hedgehog pathway inhibitors ===== | ||
* [[Vismodegib|Vismodegib (Erivedge)]] | * [[Vismodegib|Vismodegib (Erivedge)]] | ||
===== Immunomodulatory drugs (IMiDs) ===== | |||
* [[Everolimus|Everolimus (Afinitor)]] | |||
* [[Lenalidomide|Lenalidomide (Revlimid)]] | |||
* [[Pomalidomide|Pomalidomide (Pomalyst)]] | |||
===== Kinase inhibitors ===== | ===== Kinase inhibitors ===== | ||
* [[Afatinib|Afatinib (Gliotrif)]] | * [[Afatinib|Afatinib (Gliotrif)]] | ||
* [[Cabozantinib|Cabozantinib (Cometriq)]] | * [[Cabozantinib|Cabozantinib (Cometriq)]] | ||
| Line 297: | Line 252: | ||
* [[Dasatinib|Dasatinib (Sprycel)]] | * [[Dasatinib|Dasatinib (Sprycel)]] | ||
* [[Erlotinib|Erlotinib (Tarceva)]] | * [[Erlotinib|Erlotinib (Tarceva)]] | ||
* [[Gefitinib]] | |||
* [[Ibrutinib|Ibrutinib (Imbruvica)]] | * [[Ibrutinib|Ibrutinib (Imbruvica)]] | ||
* [[Idelalisib|Idelalisib (Zydelig)]] | * [[Idelalisib|Idelalisib (Zydelig)]] | ||
| Line 302: | Line 258: | ||
* [[Nilotinib|Nilotinib (Tasigna)]] | * [[Nilotinib|Nilotinib (Tasigna)]] | ||
* [[Palbociclib|Palbociclib (Ibrance)]] | * [[Palbociclib|Palbociclib (Ibrance)]] | ||
* [[Sorafenib]] | |||
* [[Sunitinib]] | |||
===== Proteasome inhibitors ===== | |||
* [[Bortezomib]] | |||
*[[Carfilzomib|Carfilzomib (Kyprolis)]] | |||
===== Radioactive agents ===== | ===== Radioactive agents ===== | ||
* [[Radium-223 chloride|Radium-223 chloride (Xofigo)]] | * [[Radium-223 chloride|Radium-223 chloride (Xofigo)]] | ||
| Line 312: | Line 273: | ||
===== VEGF receptor-2 antagonists ===== | ===== VEGF receptor-2 antagonists ===== | ||
* [[Ramucirumab|Ramucirumab (Cyramza)]] | * [[Ramucirumab|Ramucirumab (Cyramza)]] | ||
===== Antimitotic agent===== | |||
* [[Eribulin|Eribulin (Halaven)]] | |||
* [[Ixabepilone|Ixabepilone (Ixempra)]] | |||
---- | ---- | ||
Revision as of 18:37, 23 February 2015
Chemotherapeutic Agents by Category
Alkylating agents
Nitrogen mustards
- Chlorambucil (Leukeran)
- Cyclophosphamide (Cytoxan)
- Ifosfamide (Iflex)
- Melphalan (Alkeran)
- Mechlorethamine (Mustargen)
Ethylenimines
Methylhydrazines
Alkylsulfonates
Nitrosoureas
Triazenes
Platinum coordination complexes
Antimetabolites
Folic acid analogs
Pyrimidine analogs
- Azacytidine (Vidaza)
- Capecitabine (Xeloda)
- Cytarabine (Cytosar)
- Floxuridine (FUDR)
- Fluorouracil (Adrucil, Efudex)
- Gemcitabine (Gemzar)
Purine analogs
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Fludarabine (Fludara)
- Mercaptopurine (Purinethol)
- Nelarabine (Arranon)
- Pentostatin (Nipent)
- Thioguanine (Tabloid)
Ribonucleotide reductase inhibitors
Natural products
Vinca alkaloids
- Vinblastine (Velban, Velsar)
- Vincristine (Oncovin, Vincasar)
- Vincristine liposome (Marqibo)
- Vinorelbine (Navelbine)
Taxanes
Epipodophyllotoxins
Camptothecins
Antineoplastic antibiotics
- Bleomycin (Blenoxane)
- Dactinomycin (Cosmegen)
- Daunorubicin (Daunoxome)
- Doxorubicin (Adriamycin, Rubex)
- Epirubicin (Ellence)
- Idarubicin (Idamycin)
- Mitomycin C (Mutamycin)
- Mitoxantrone (Novantrone)
- Valrubicin (Valstar)
Antineoplastic enzymes
Hormones and Antagonists
Adrenocortical suppressants
Antiandrogens
- Abiraterone (Zytiga)
- Bicalutamide (Casodex)
- Dutasteride (Avodart)
- Enzalutamide (Xtandi)
- Finasteride (Proscar)
- Flutamide (Eulexin)
- Ketoconazole (Nizoral)
- Leuprolide (Lupron)
- Nilutamide (Nilandron)
- Triptorelin (Trelstar)
Steroid synthesis inhibitors
- Abiraterone (Zytiga)
- Aminoglutethimide (Cytadren)
- Anastrozole (Arimidex)
- Exemestane (Aromasin)
- Letrozole (Femara)
- Mitotane (Lysodren)
Androgen receptor inhibitors
5α-reductase inhibitors
GnRH agonists
GnRH antagonists
Aromatase inhibitors
Selective estrogen receptor modulators
Biologics
Antibody medications
- Cetuximab (Erbitux)
- Denosumab (Xgeva)
- Ibritumomab tiuxetan (Zevalin)
- Ipilimumab (Yervoy)
- Nivolumab (Opdivo)
- Obinutuzumab (Gazyva)
- Ofatumumab (Arzerra)
- Pembrolizumab (KEYTRUDA)
Antibody-drug conjugates
Anti-HER2 medications
Enzymes
IL-6 inhibitors
IL-2 inhibitors
Immunotherapy
Immunomodulatory drugs (IMiDs)
Hematopoietic Growth Factors
Erythrocyte growth factors
Granulocyte growth factors
Megakaryocyte growth factors
Supportive Medications
Chemotherapy protective agents
- Amifostine (Ethyol)
- Cyanocobalamin
- Dexrazoxane (Zinecard)
- Folinic acid (Leucovorin)
- Glucarpidase (Voraxaze)
- Levoleucovorin (Fusilev)
- Mesna (Mesnex)
Antiemetic agents
RANK ligand inhibitors
Miscellaneous
Bisphosphonate
HDAC inhibitors
Hedgehog pathway inhibitors
Immunomodulatory drugs (IMiDs)
Kinase inhibitors
- Afatinib (Gliotrif)
- Cabozantinib (Cometriq)
- Crizotinib (Xalkori)
- Dasatinib (Sprycel)
- Erlotinib (Tarceva)
- Gefitinib
- Ibrutinib (Imbruvica)
- Idelalisib (Zydelig)
- Lapatinib (Tykerb)
- Nilotinib (Tasigna)
- Palbociclib (Ibrance)
- Sorafenib
- Sunitinib
Proteasome inhibitors
Radioactive agents
Somatostatin analogues
VEGF receptor-2 antagonists
Antimitotic agent